TNXP
Tonix Pharmaceuticals Holding Corp
Price:  
0.14 
USD
Volume:  
15,305,754.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TNXP WACC - Weighted Average Cost of Capital

The WACC of Tonix Pharmaceuticals Holding Corp (TNXP) is 7.0%.

The Cost of Equity of Tonix Pharmaceuticals Holding Corp (TNXP) is 7.90%.
The Cost of Debt of Tonix Pharmaceuticals Holding Corp (TNXP) is 7.00%.

Range Selected
Cost of equity 6.40% - 9.40% 7.90%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.0% - 8.0% 7.0%
WACC

TNXP WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.56 0.8
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.40% 9.40%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.47 0.47
Cost of debt 7.00% 7.00%
After-tax WACC 6.0% 8.0%
Selected WACC 7.0%